A carregar...
Curaxin CBL0137 has the potential to reverse HIV-1 latency
A cure for human immunodeficiency virus type-1 (HIV-1) has been hampered by the limitation of current combination antiretroviral therapy (cART) to address the latent reservoirs in HIV-1 patients. One strategy proposed to eradicate these reservoirs is the “shock and kill” approach, where latency-reve...
Na minha lista:
| Publicado no: | J Med Virol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599568/ https://ncbi.nlm.nih.gov/pubmed/30989696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.25487 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|